Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/9989 stock hub

HKG/9989 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/9989is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.7B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/9989

In the news

Latest news · HKG/9989

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E38.6

P25 10.7P50 17.9P75 38.5

ROE3

P25 -14.7P50 2P75 9.4

ROIC4.5

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/9989 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

CNY

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	2,150
Employees Change	224%
Employees Change Percent	11.63
Enterprise value	HKD 16.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100003YN2
Last refreshed	2026-05-10
Market cap	HKD 16.7B
Price	HKD 4.94
Price currency	HKD
Rev Per Employee	2,863,120.01x
Sector	Healthcare
Sic	2834
Symbol	hkg/9989
Website	https://www.hepalink.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.59%
EV Earnings	38.11x
EV/EBIT	22.93x
EV/EBITDA	14.54x
EV/FCF	10.04x
EV/Sales	2.64x
FCF yield	9.83%
P/B ratio	1.2x
P/E ratio	38.63x
P/S ratio	2.71x
PE Ratio10 Y	51.49x
PE Ratio3 Y	40.7x
PE Ratio5 Y	43.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.53%
EBITDA Margin	17.56%
FCF margin	26.67%
Gross margin	32.87%
Gross Profit	HKD 2B
Gross Profit Growth	7.48%
Gross Profit Growth Q	19.24%
Gross Profit Growth3 Y	-6.43%
Gross Profit Growth5 Y	-0.61%
Net Income	HKD 432.5M
Net Income Growth	-41.31%
Net Income Growth Q	19.79%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-12.04%
Net Income Growth5 Y	-16.05%
Pretax Margin	7.97%
Profit Margin	7.03%
Profit Per Employee	HKD 201,146
Profitable Years	2
ROA	2.26
Roa5y	1.95
ROCE	4.97
ROE	3.04
Roe5y	1.88
ROIC	4.47
Roic5y	3.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.32%
Cagr3y	4.06%
Cagr5y	-12.73%
Div CAGR3	87.68%
EPS Growth	-41.31
EPS Growth Q	19.78
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-12.01
EPS Growth5 Y	-16.73
FCF Growth	-13.73%
FCF Growth Q	-29.31%
FCF Growth5 Y	24.45%
OCF Growth	-16.8%
OCF Growth Q	-30.75%
OCF Growth10 Y	8.34%
OCF Growth5 Y	18.02%
Revenue Growth	2.15x
Revenue Growth Q	-4.55x
Revenue Growth Years	1x
Revenue Growth3 Y	-6.14x
Revenue Growth5 Y	0.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.31
Assets	HKD 19.3B
Cash	HKD 4B
Current Assets	HKD 11B
Current Liabilities	HKD 5.1B
Debt	HKD 3.7B
Debt EBITDA	HKD 3.31
Debt Equity	HKD 0.27
Debt FCF	HKD 2.26
Equity	HKD 13.9B
Interest Coverage	8.74
Liabilities	HKD 5.4B
Long Term Assets	HKD 8.3B
Long Term Liabilities	HKD 307.9M
Net Cash	HKD 279.6M
Net Cash By Market Cap	HKD 1.67
Net Debt EBITDA	HKD -0.26
Net Debt Equity	HKD -0.02
Net Debt FCF	HKD -0.17
Tangible Book Value	HKD 10.9B
Tangible Book Value Per Share	HKD 7.44
WACC	5.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.15
Inventory Turnover	0.8
Net Working Capital	HKD 5.5B
Quick ratio	1.1
Working Capital	HKD 5.8B
Working Capital Turnover	HKD 1.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	HKD 0.27
Dividend Years	1
Dividend Yield	5.5%
Ex Div Date	2025-05-26
Last Dividend	HKD 0.27
Payout Ratio	110.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	12.32%
200-day SMA	5.51
3Y total return	12.68%
50-day SMA	5.03
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.38%
All Time High	19.48
All Time High Change	-74.64%
All Time High Date	2020-08-07
All Time Low	2.39
All Time Low Change	106.69%
All Time Low Date	2024-02-05
ATR	0.09
Beta	0.45
Ch YTD	-5.18
High	4.98
High52	7.26
High52 Date	2025-07-21
High52ch	-31.96%
Low	4.88
Low52	4.4
Low52 Date	2025-05-26
Low52ch	12.27%
Ma50ch	-1.71%
Price vs 200-day SMA	-10.34%
RSI	50.13
RSI Monthly	48.6
RSI Weekly	41.55
Sharpe ratio	0.51x
Sortino ratio	0.98
Total Return	5.51%
Tr YTD	-5.18
Tr1m	-2.76%
Tr1w	2.7%
Tr3m	-10.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 709.7M
Operating Income Growth	0.95
Operating Income Growth Q	40.89
Operating Income Growth3 Y	-8.37
Operating Income Growth5 Y	-5.97
Operating margin	11.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	413,068,334%
Net Borrowing	-488,076,233.6
Shares Insiders	4.53%
Shares Institutions	2.48%
Shares Qo Q	0.04%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.6B
Average Volume	307,600x
Bv Per Share	9.43
CAPEX	HKD -115.1M
Ch1m	-2.76
Ch1w	2.7
Ch1y	5.78
Ch3m	-10.83
Ch3y	3.56
Ch5y	-54.51
Ch6m	-9.85
Change	0.82%
Change From Open	-0.8
Close	4.9
Days Gap	1.63
Depreciation Amortization	375,904,320.4
Dollar Volume	1,437,540
Earnings Date	2026-04-29
EBIT	HKD 709.7M
EBITDA	HKD 1.1B
EPS	HKD 0.29
F Score	7
FCF	HKD 1.6B
FCF EV Yield	9.96x
Financing CF	-963,294,647
Fiscal Year End	December
Founded	1,998
Goodwill	2,612,700,854.3
Graham Number	3.43852
Graham Upside	-30.39
Income Tax	HKD 65.7M
Investing CF	-932,744,753
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	HKD 0.64
Lynch Upside	-87.06
Ma150	5.26
Ma150ch	-6.1%
Ma20	4.92
Ma20ch	0.43%
Net CF	-147,167,616
Next Earnings Date	2026-08-28
Open	4.98
P FCF Ratio	10.18
P OCF Ratio	9.51
Payment Date	2025-07-07
Position In Range	60
Ppne	2,664,043,445
Price Date	2026-05-08
Price EBITDA	HKD 15.46
Ptbv Ratio	1.53
Relative Volume	0.94x
Revenue	6,155,708,019x
Tax By Revenue	1.07x
Tax Rate	13.4%
Tr6m	-9.85%
Volume	291,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/9989 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.5%

$0.27 annual per share

Payout ratio

+110.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+5.5%

Next ex-dividend date: 2025-05-26

Performance

HKG/9989 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/9989?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.5%

Share of float held by funds and institutions

Insider ownership

+4.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

HKG/9989 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.1

Neutral momentum band

Price vs 200-day MA

-10.3%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/9989

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/9989 stock rating?

hkg/9989 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/9989 analysis?

The full report lives at /stocks/hkg/9989/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/9989?

The latest report frames hkg/9989 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/9989 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.